AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 149 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,142 | +88.4% | 591 | +17.7% | 0.00% | +100.0% |
| Q1 2024 | $12,811 | +182.0% | 502 | 0.0% | 0.00% | – |
| Q4 2023 | $4,543 | +46.2% | 502 | +3.1% | 0.00% | – |
| Q3 2023 | $3,107 | +77.3% | 487 | +208.2% | 0.00% | – |
| Q2 2023 | $1,752 | -17.9% | 158 | +13.7% | 0.00% | – |
| Q1 2023 | $2,134 | -35.0% | 139 | -6.1% | 0.00% | – |
| Q4 2022 | $3,284 | – | 148 | +825.0% | 0.00% | – |
| Q3 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 16 | -93.7% | 0.00% | -100.0% |
| Q1 2022 | $5,000 | – | 252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |